Explore the Associations of Behavioral Factors With Treatment Adherence in Axial Spondyloarthritis Patients Treated With Biotherapy.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-06-21

Study Completion Date

2022-06-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The management of chronic inflammatory rheumatism, including spondyloarthritis (SpA), has been revolutionized in recent decades with the arrival of biological therapy. The success of the current therapeutic strategy is also based on therapeutic compliance. If therapeutic adherence in rheumatoid arthritis patient (RA) is only 66%, it seems even worse in SpA. Few studies report quantitatively the adherence of SpA patients, as well as the predictive or associated factors. The objective of this study is to assess the patient adherence to biologics in patients with axial SpA (SpAax), and to investigate factors influencing this adherence, in particular the association with vaccination coverage, dietary behavior, and digital health tools.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Impact of Behavioral Factors on Treatment Adherence in a Sample of Rheumatoid Arthritis Patients

NCT03754855

Arthritis, Rheumatoid

COMPLETED

RhEumatoid Arthritis MEDIcation Adherence

NCT05413759

Rheumatoid Arthritis

RECRUITING NA

Medication Adherence in Rheumatic Diseases

NCT06018350

Chronic Rheumatic Diseases

COMPLETED NA

COMorbidities and EDucation in SPondyloArthritis Study

NCT02374749

Axial Spondyloarthritis

COMPLETED NA

Psychosocial and Functional Factors in AxSpA

NCT06688929

Spondyloarthropathies Ankylosing Spondylitis (AS)

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Multicentric cross-sectional survey of patients seen in the context of a rheumatology consultation or hospitalization.

On the occasion of a single visit in consultation or hospitalization, an anonymous self-questionnaire will be distributed to patients undergoing SpAax follow-up to assess their compliance with biologic drugs, their vaccination coverage, their diet, the presence of a fibromyalgia syndrome or inflammatory bowel disease, intestinal disorders, regular physical activity and sedentary lifestyle, the frequency and mode of use of mobile applications and/or connected objects related to health, the presence of catastrophic thoughts and the presence of anxiety and depressive disorders. Medical data relevant to routine care will be collected.(Age, sex, weight, height, tobacco and alcohol use, disease characteristics, SpA treatment, comorbidities)

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Axial Spondyloarthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

self-questionnaire to patients undergoing SpAax follow-up

On the occasion of a single visit in consultation or hospitalization, an anonymous self-questionnaire will be distributed to patients undergoing SpAax follow-up

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient \>18 years old with axial spondyloarthritis according to ASAS criteria and treated with biotherapy.
* French-speaking, without any understanding problems.

Exclusion Criteria

* Patients under curatorship, guardianship or other legal protection
* Patients refusing to consent to participate in research
* Pregnant and breastfeeding women.

Minimum Eligible Age

18 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

No